Abstract
Curcumin (diferuloylmethane), a biologically active ingredient derived from rhizome of the plant Curcuma longa, has potent anticancer properties as demonstrated in a plethora of human cancer cell lines/animal carcinogenesis model and also acts as a biological response modifier in various disorders. We have reported previously that dietary supplementation of curcumin suppresses renal ornithine decarboxylase (Okazaki et al. Biochim Biophys Acta 1740:357–366, 2005) and enhances activities of antioxidant and phase II metabolizing enzymes in mice (Iqbal et al. Pharmacol Toxicol 92:33–38, 2003) and also inhibits Fe-NTA-induced oxidative injury of lipids and DNA in vitro (Iqbal et al. Teratog Carcinog Mutagen 1:151–160, 2003). This study was designed to examine whether curcumin possess the potential to suppress the oxidative damage caused by kidney-specific carcinogen, Fe-NTA, in animals. In accord with previous report, at 1 h after Fe-NTA treatment (9.0 mg Fe/kg body weight intraperitoneally), a substantial increased formation of 4-hydroxy-2-nonenal (HNE)-modified protein adducts in renal proximal tubules of animals was observed. Likewise, the levels of 8-hydroxy-2′-deoxyguanosine (8-OHdG) and protein reactive carbonyl, an indicator of protein oxidation, were also increased at 1 h after Fe-NTA treatment in the kidneys of animals. The prophylactic feeding of animals with 1.0% curcumin in diet for 4 weeks completely abolished the formation of (i) HNE-modified protein adducts, (ii) 8-OHdG, and (iii) protein reactive carbonyl in the kidneys of Fe-NTA-treated animals. Taken together, our results suggest that curcumin may afford substantial protection against oxidative damage caused by Fe-NTA, and these protective effects may be mediated via its antioxidant properties. These properties of curcumin strongly suggest that it could be used as a cancer chemopreventive agent.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Several lines of evidence indicate that oxidative stress may play an important role in various pathological conditions, including cancer, neurodegeneration, atherosclerosis, diabetes, heart diseases, retinal degeneration, and rheumatoid arthritis, as well as drug-associated toxicity, postischemic reoxygenation injury, and aging [1]. We have developed a model of iron-induced oxidative tissue damage and carcinogenesis using ferric nitrilotriacetate (Fe-NTA), an iron chelate compound in rats and mice [2, 3]. This is a unique model characterized by (i) high incidence of pulmonary metastasis and peritoneal invasion (ii) high incidence of tumor associated mortality, and (iii) possible involvement of reactive oxygen species (ROS) in carcinogenic process [2, 3]. Fe-NTA-induced free radicals cause molecular oxidative damage [4]. The susceptibility of polyunsaturated fatty acids to radical attack results in the destruction of membrane lipids and the production of lipid peroxides and their byproducts, such as aldehydes [5]. Malondialdehyde (MDA), and 4-hydroxy-2-alkenals (4-HAD), such as 4-hydroxy-2-nonenal (HNE), are the major end products derived from the breakdown of polyunsaturated fatty acids and related esters [5]. HNE is a highly reactive electrophile that exhibits a variety of cytopathological effects because of its facile reactivity with biological molecules, particularly with proteins [6]. Toyokuni et al. [7, 8] have provided direct evidence for the formation of aberrant proteins, including HNE-modified and MDA-modified proteins, in rat kidney following treatment with Fe-NTA, a consequence of oxidative stress. The involvement of oxidative stress in this model of renal carcinogenesis is also suggested by increased levels of markers of oxidative DNA damage, including the formation of 8-hydroxydeoxyguanosine (8-OHdG) [9–12]. Since 8-OHdG adducts can cause misreading of the DNA sequence during replication, due to G- for -T base substitutions [13], they might result in a significant activation of oncogenes [14]. Accordingly, it seems likely that both of the established products play key roles in Fe-NTA-induced toxicity and carcinogenicity. Although the mechanism of Fe-NTA-induced genotoxicity is not known, it has been suggested that ROS might contribute to its renal carcinogenicity [2–4, 7–14]. Therefore, inhibition of markers of oxidative damage in target organs by antioxidants might be expected to be effective for prevention of radical-mediated carcinogenesis.
Curcumin is a major yellow pigment in turmeric (the ground rhizome of Curcuma longa Linn), which is widely used as a spice and coloring agent in several foods, such as curry, mustard, and potato chips, as well as cosmetics and drugs [15, 16]. A wide range of biological and pharmacological activities of curcumin have been investigated [15, 16]. Curcumin is a potent inhibitor of mutagenesis and chemically induced carcinogenesis [17–19]. It possesses many therapeutic properties including anti-inflammatory and anticancer activities [20]. Curcumin is currently attracting strong attention due to its antioxidant potential as well as relatively low toxicity to rodents [15–20]. Curcumin is an inhibitor of neutrophil responses [21] and superoxide generation in macrophages [21]. In previous studies, we have shown that dietary supplementation of curcumin suppresses renal ornithine decarboxylase and enhances the activities of antioxidant and phase II metabolizing enzymes in mice [22, 23] and also inhibits Fe-NTA-induced oxidative injury of lipids and DNA in vitro [24]. These findings support the need for further study. Therefore, the present study was designed to examine whether curcumin possesses the potential to suppress the oxidative damage caused by Fe-NTA. Curcumin was found to suppress Fe-NTA-induced formation of: (i) HNE-modified protein adducts, (ii) 8-OHdG, and (iii) protein reactive carbonyl contents in the kidneys of animals.
Materials and methods
Chemicals
Bovine serum albumin (BSA), curcumin, 2,4-dinitrophenyhydrazine (2,4-DNPH), guanidine–HCl, tris–HCl, ethylenediamine tetraacetic acid (EDTA), sodium bicarbonate, trichloroacetic acid (TCA), ethyl acetate, and nitrilotriacetic acid disodium salt (NTA) were purchased from either Sigma Chemical Company, St Louis, MO, USA, or Aldrich, USA. All other chemicals/reagents were of highest quality available from Wako pure chemical industries Ltd, Osaka, Japan.
Antibodies
Monoclonal antibody, HNEJ-2, specific for HNE-modified protein adducts [25] and N45.1, specific for 8-OHdG [26], respectively, were used for immunohistochemistry and kindly provided by Dr. S. Toyokuni (Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Japan).
Preparation and injection of Fe-NTA solution
A solution of Fe-NTA was prepared by the method of Awai et al. [27] with slight modification. Briefly, ferric nitrate (FeNO3) and NTA was dissolved in double distilled water. The respective solutions were mixed to achieve a molar ratio of 1:3 of Fe-NTA. The pH was adjusted to 7.4 with sodium bicarbonate with constant stirring. All solutions were prepared fresh immediately before its use. Fe-NTA was injected intraperitoneally into the animals.
Animals and experimental groups
Animal experiments were approved by animal care committee of Okayama University Medical School, care and handling of the animals was in accordance with National Institutes of Health guidelines. Male ddY mice (4–6 weeks old) weighing 20–30 g obtained from Shizuoka Laboratory Animal Centre, Shizuoka, Japan, were used. They were kept in a temperature controlled (25°C) room with alternating 12-h/12-h light/dark cycles, and were allowed to acclimatize for 1 week before study and had free access to standard laboratory chow and water ad libitum. The basic diet without curcumin supplement is referred to as the control diet and that supplemented with 1.0% curcumin is referred to as the curcumin diet.
The animals were divided into four groups consisting of n = 6 in each. The animals of groups I & II received control (normal) diet and served as controls, whereas the animals of groups III & IV received a prophylactic treatment of 1.0% curcumin in diet for 4 weeks. After 4 weeks of dietary supplementation of curcumin, the animals of groups II & III received an intraperitoneal injection of Fe-NTA at a dose of 9.0 mg Fe/kg body weight. All of these animals were killed at 1 h after the treatment with Fe-NTA or saline by cervical decapitation and both kidneys of each animal were removed immediately. One kidney of each animal was fixed in 10% phosphate buffered formalin overnight, and embedded in paraffin, sectioned at 3.5 μm, and mounted on glass slides either for hematoxylin/eosin staining or immunohistochemistry. The other kidney of each animal was homogenized in 0.1 M phosphate buffer, pH 7.4, containing 1.15% KCl, for the preparation of cytosol as described previously [28, 29] and was used for the assay of protein reactive carbonyl contents.
Immunohistochemistry
The immunohistochemical studies were conducted using avidin–biotin complex (ABC) peroxidase method of Hsu et al. [30] as described by Toyokuni et al. [7]. Samples were fixed with 10% phosphate buffered formalin overnight and embedded in paraffin. After deparaffinization and dehydration through a graded xylene/ethanol series, incubation in 3.0% hydrogen peroxide in 10 mM phosphate buffered saline (PBS) was applied for the inhibition of endogenous peroxidase. After these procedures, normal rabbit serum (Dako, Glostrup, Denmark; diluted to 1:10) for the inhibition of non-specific binding of secondary antibody, partially purified mouse monoclonal antibody, HNEJ-2 against HNE-modified protein adducts (10 μg/ml) or N45.1 against 8-OHdG (10 μg/ml), followed by biotinylated rabbit anti-mouse IgG antiserum (Dako; diluted to 1:100) and ABC (Vectastain ABC Kit, Vector Laboratories, Burlingame, CA; diluted to 1:100) were sequentially applied to the sections. Finally, the sections were incubated with liquid 3,3-diaminobentidine (DAB) for 3 min. Nuclear staining was performed with Harris’s hematoxylin solution (controls using preimmune mouse serum and PBS instead of antibody against HNE-modified protein adducts or 8-OHdG showed no or negligible positivity).
Assay of protein reactive carbonyl contents
Protein reactive carbonyl contents in kidney were assayed by the method of Levine et al. [31] as described by Iqbal et al. [28, 29]. An aliquot 0.5 ml (10%, w/v) of renal 105,000×g cytosolic fractions was treated with an equal volume of 2,4-DNPH (0.1%) in 2 N HCl and incubated for 1 h at room temperature. This mixture was treated with 0.5 ml TCA (10%, w/v) and after centrifugation the precipitate was extracted three times with ethanol/ethyl acetate (1/1, v/v). The protein sample was then dissolved with 2.0 ml of solution containing guanidine hydrochloride (8 M)/EDTA (13 mM)/Tris (133 mM) (pH 7.2) and UV absorbance was measured at 365 nm. The results were expressed as n moles of 2,4-DNPH-incorporated/mg protein based on the molar extinction coefficient of 21.0 mM−1 cm−1. Protein concentration in all samples was determined using a BCA (bicinchonic acid) protein assay kit (Pierce, Rockford, IL).
Statistical analysis
Statistical significance was carried out using Student’s t-test. A P-value less than 0.05 was considered as significant difference. All data were expressed as mean ± SE of six animals.
Results
Since HNE, a major aldehydic product of lipid peroxidation, is believed to be largely responsible for cytopathological effects observed during oxidative stress [5–8], we evaluated the effect of curcumin against Fe-NTA-induced formation of HNE-modified protein adducts in kidney. The results of these investigations, together with the finding that 4-hydroxyalkenals, in particular HNE, are formed during NADPH-Fe-stimulated peroxidation of liver microsomal lipids [32], may help to elucidate the mechanism by which lipid peroxidation causes deleterious effects on cells and cell constituents after Fe-NTA treatment. Immunohistochemical examination revealed that at 1 h after the administration of Fe-NTA there was an increased formation of HNE-modified protein adducts in the form of yellowish brown reaction product in the cytoplasm of the renal proximal tubules (Fig. 1b), presumably resulting from the reaction of HNE with cytoplasmic constituents [32]. These HNE-protein adducts were also detected in the epithelium undergoing necrotic changes in the form of patchy reaction. The tubular lumen contains a small amount of this protein, suggesting that the HNE-modified protein adducts are released in the tubular lumen possibly for its elimination in urine. The HNE-modified protein adducts are primarily detectable in cytoplasm; however, their intranuclear localization could not be ruled out completely. In contrast, prophylactic treatment of animals with 1.0% curcumin in diet almost completely suppressed the Fe-NTA-induced increase formation of HNE-modified protein adducts in kidney (Fig. 1c). In saline-treated control animals, these HNE-proteins were either absent or detected as mild intracytoplasmic reaction products in some renal tubular epithelium (Fig. 1a). Similarly, in curcumin (1.0%) alone-pretreated animals these HNE-proteins were also not detected (data not shown).
Since 8-OHdG, a DNA base modified product, is one of the most commonly used marker for the evaluation of oxidative DNA damage and is thought to be implicated in mutagenesis and carcinogenesis [9–14], we studied the effect of curcumin on Fe-NTA-induced formation of 8-OHdG in kidney. As shown in Fig. 2a, in the renal cortices of saline-treated control animals, faint nuclear staining of renal tubular cells was observed, particularly in the nuclear membranes. Whereas in Fe-NTA-treated animals, intense nuclear staining of renal proximal tubular cells (Fig. 2b), as well as distal tubular cells, was observed. However, 8-OHdG-positive cells were observed to be scattered in the renal proximal tubules even in saline-treated control animals. In contrast to the intense nuclear staining present in Fe-NTA-treated animal’s kidney, only slight nuclear staining, almost similar to the staining of saline-treated control animals, was observed in the renal proximal tubules of curcumin and Fe-NTA-treated animals (Fig. 2c). Similarly, a faint nuclear staining was also detected in kidney of curcumin (1.0%) alone-pretreated animals (data not shown).
Because studies have shown that oxidation of some amino acid residues of proteins such as lysine, arginine, and proline leads to the formation of carbonyl derivatives that affects the nature and function of proteins [33]. The presence of carbonyl groups has become a widely accepted measure of oxidative damage of proteins under the conditions of oxidative stress, which react with 2,4-DNPH to form stable hydrazone derivatives [34]. Therefore, we analyzed the effect of curcumin on Fe-NTA-induced formation of protein reactive carbonyl contents in kidney as a measure of oxidative damage. As shown in Table 1, at 1 h after Fe-NTA treatment, a 1.2-fold increase in the level of protein reactive carbonyl contents in kidney comparison with the saline-treated control was observed. Curcumin pretreatment was thus able to almost completely prevent Fe-NTA-induced oxidation of protein, as monitored by measuring the formation of protein reactive carbonyl contents. Curcumin alone treatment (1.0% diet) was without any effect on the formation of protein reactive carbonyl contents in kidney (data not shown).
Discussion
Recently, there has been an increasing interest in protective function of dietary antioxidants, which are candidates for cancer chemoprevention and for extending lifespan [35]. Several antioxidants, such as vitamin E, vitamin C, β-carotene, uric acid, ubiquinols, and flavonoids, have been found to play important roles in the non-enzymatic protection against oxidative stress [35–38]. However, it has been pointed out that one component in these antioxidants is not enough to prevent carcinogenesis. Therefore, a small number of the components of food are anticipated to have effects on the prevention of carcinogenesis. The efficacy of these chemopreventive agents has been related to their antioxidant potential of reducing/or inhibiting free radical mediated damage to DNA, lipids, and proteins [35–38]. In addition, anticarcinogenic effects of these agents are also reported to be related to their potential of decreasing oxidative stress [35–38] and/or inducing antioxidant and phase II metabolizing enzymes [23].
Oxidative damage to biomolecules has been postulated to be involved in several chronic diseases [39]. Fe-NTA is known as a complete renal carcinogen as well as renal and hepatic tumor promoter [2, 3, 40], acting by inducing ROS generation in the tissues. It was also shown that Fe-NTA down-regulates hepatic and renal quinone reductase activity and produces an increase in protein reactive carbonyl contents [28, 29]. Toyokuni et al. [11, 12] have reported that all four DNA bases are modified in the renal chromatin of rats within 24 h of Fe-NTA treatment. These lesions are typical products of hydroxyl radical reactions. The ability of Fe-NTA to promote DNA and membrane damage has been postulated as a critical mechanism in renal carcinogenesis associated with the intraperitoneal injection of this complex [7–12, 29]. Several antioxidants have been reported to show protective effects against Fe-NTA-induced toxicity and carcinogenesis [24, 41–45]. In this study, we investigated the antioxidant effects of dietary curcumin, on renal oxidative damage incurred by Fe-NTA.
Because HNE is considered to be the most reliable index of free radical-induced lipid peroxidation and exhibits variety of cytopathological effects such as enzyme inhibition, inhibition of DNA and RNA synthesis, inhibition of protein synthesis, and induction of heat shock proteins [6]. It is highly cytotoxic to many types of cells such as hepatocytes, mammalian fibroblast, and Ehrlich ascites tumor cells [6]. Furthermore, this aldehyde has genotoxic and mutagenic effect as well as inhibitory effect on cell proliferation [6]. It has also been proposed that HNE exerts these effects because of its facile reactivity with biological molecules, particularly with protein via its reactive aldehyde group, is a key factor in the toxicity and carcinogenicity of Fe-NTA [7, 8, 29]. Thus, we were prompted to study whether dietary curcumin is able to block the increase formation of HNE—modified protein adducts in kidney of Fe-NTA-treated animals. Our data demonstrated that prophylactic treatment of curcumin to animals can efficiently attenuate this increase, suggesting the preventive potential of curcumin and indicating that antioxidant property may be responsible for the biological effects of curcumin.
In our next experiment, we assessed the effect of dietary curcumin on Fe-NTA-mediated increase in the formation of 8-OHdG in kidney. A great amount of evidence points to the role of oxidative DNA damage in carcinogenesis [9–14]. The most ubiquitous oxidative DNA base modification is 8-OHdG, and the increase in urinary excretion of 8-OHdG reflects the oxidative DNA damage in vivo [9, 46]. It has been established that Fe-NTA administration results in enhanced formation of 8-OHdG and high incidence of renal carcinoma in rats and mice [2, 3, 9–12, 46]. Lipid peroxidation has been shown to promote the formation of 8-OHdG by production of HNE-modified protein adducts [7, 8]. In accordance with the previous reports [7, 47], we have demonstrated that the levels of 8-OHdG in renal DNA change nearly in parallel with urinary 8-OHdG after Fe-NTA treatment [48], and curcumin suppresses such an increase in 8-OHdG formations. These findings are consistent with our previous in vitro report [24] and other earlier observations that several antioxidants such as 2-mercaptoethanol and N-acetylcysteine prevent Fe-NTA-mediated DNA damage [47]. Considering the number of reports demonstrating a close relation between 8-OHdG formation and carcinogenicity [7–14], it seems likely that 8-OHdG formations might participate in Fe-NTA-induced renal carcinogenesis [49]. In this respect, our data revealing that curcumin administration can protect against such an increase in 8-OHdG formation, suggest that curcumin might be effective against Fe-NTA-mediated carcinogenicity by acting as an antioxidant. Though the mechanism of 8-OHdG formation due to cellular oxidation is unclear, the present data are of interest in highlighting a possible link between lipid peroxidation and oxidative DNA damage. HNE also reacts with deoxyguanosine, resulting in the formation of exocyclic adducts [50]. In the presence of t-butylhydroperoxide, HNE is readily epoxidized to yield 2,3-epoxy-4-hydroxynonanal, which is more mutagenic and tumorigenic than the parent aldehyde [51].
Our next experiments were directed toward further evaluating whether the preventive effect of curcumin for Fe-NTA-caused damage is mediated via its antioxidant potential. Our data clearly demonstrated that prophylactic treatment of animals with curcumin inhibited Fe-NTA-induced protein oxidation as monitored by measuring protein reactive carbonyl contents in kidney. The method of protein 2,4-DNPH post labeling originally introduced by Levine et al. [31], for isolated proteins has been demonstrated in this study to be useful monitor of Fe-NTA-mediated oxidative damage. Based on the facts [52] that free radicals convert amino acid side chains to carbonyl moieties in vitro, it was believed that method was specific for oxidized proteins. However, studies [53–56] have shown that the attachment of histidine, cysteine, and lysine residues of the proteins to the α,β-double bond of HNE also generates protein carbonyl groups detected by reaction with 2,4-DNPH and by tritium labeling via reduction of carbonyl groups with tritiated sodium borohydride. The origin of carbonyl group in renal proteins of Fe-NTA-treated animals is still invalid; however, there is no doubt that protein carbonyl measurement using the 2,4-DNPH post-labeling method is useful for monitoring free radical action in vivo and provides indirect evidence that free radical-induced covalent modification of renal proteins occurs in this carcinogenesis. Thus our data clearly demonstrated that curcumin treatment inhibits Fe-NTA-induced protein oxidation as monitored by measuring the formation of protein reactive carbonyl contents in kidney provides further strong clear indication that this agent imparts its preventive action, a least in part, via its antioxidant property.
Conclusion
In brief, our study clearly demonstrated that dietary curcumin afford strong protection against oxidative damage caused by Fe-NTA exposure and these protective effects may be mediated via its strong antioxidant properties. However, because the markers studied here are regarded as early markers of renal carcinogenesis, we suggest that curcumin may be developed as a potent cancer chemopreventive agent against renal carcinogenesis and other adverse effects of Fe-NTA exposure. The results described herein may contribute toward a better understanding of the biological mechanisms associated with health protection by curcumin.
References
Hogg N (1998) Free radicals in disease. Semin Reprod Endocrinol 16:241–288
Okada S (1996) Iron induced carcinogenesis: the role of reactive oxygen free radicals. Pathol Int 46:311–332
Athar M, Iqbal M (1998) Ferric nitrilotriacetate promotes N-diethylnitrosoamine-induced renal tumorigenesis in rat: implications for the involvement of oxidative stress. Carcinogenesis 19:1133–1139. doi:10.1093/carcin/19.6.1133
Dutta KK, Zhong Y, Liu YT et al (2007) Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci 98:1845–1852. doi:10.1111/j.1349-7006.2007.00619.x
Comporti M (1999) Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology. Free Radic Res 28:623–635. doi:10.3109/10715769809065818
Esterbauer H, Schaur JS, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128. doi:10.1016/0891-5849(91)90192-6
Toyokuni S, Uchida K, Okamoto K et al (1994) Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 91:2616–2620. doi:10.1073/pnas.91.7.2616
Uchida K, Fukuda A, Kawakishi S et al (1995) A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch Biochem Biophys 317:405–411. doi:10.1006/abbi.1995.1181
Umemura T, Sai K, Takagi A et al (1990) Formation of 8-hydroxy deoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis 11:345–347. doi:10.1093/carcin/11.2.345
Yamaguchi R, Hirano T, Asami S et al (1996) Increase in the 8-hydroxyguanine repair activity in the rat kidney after the administration of a renal carcinogen, ferric nitrilotriacetate. Environ Health Perspect 104:651–653. doi:10.2307/3432839
Toyokuni S, Mori T, Dizdaroglu M (1994) DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 57:123–128. doi:10.1002/ijc.2910570122
Toyokuni S, Mori T, Hiai H et al (1995) Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int J Cancer 62:309–313. doi:10.1002/ijc.2910620313
Shibutani S, Takeshita M, Grollman AP (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349:431–434. doi:10.1038/349431a0
Kamiya H, Miura K, Ishikawa H et al (1992) c-Ha-ras containing 8-hydroxyguanine at codon 12 induces point mutations at the modified and adjacent positions. Cancer Res 52:3483–3485
Surh YJ, Chun KS (2007) Cancer chemopreventive effects of curcumin. Adv Exp Med Biol 595:1449–1720
Ferguson LR, Philpott M (2007) Cancer chemoprevention by dietary bioactive components that target the immune response. Curr Cancer Drug Targets 7:459–464. doi:10.2174/156800907781386605
Lin JK (2007) Molecular targets of curcumin. Adv Exp Med Biol 595:227–243. doi:10.1007/978-0-387-46401-5_10
Kuttan G, Kumar KB, Guruvayoorappan C (2007) Antitumor, anti-invasion and antimetastatic effects of curcumin. Adv Exp Med Biol 595:173–184. doi:10.1007/978-0-387-46401-5_6
Johnson JJ, Mukhtar H (2007) Curcumin for chemoprevention of colon cancer. Cancer Lett 255:170–181. doi:10.1016/j.canlet.2007.03.005
Srimal RC, Dhawan BN (1973) Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25:447–452
Srivastava R (1989) Inhibition of neutrophil response by curcumin. Agents Actions 28:298–303. doi:10.1007/BF01967418
Okazaki Y, Iqbal M, Okada S (2005) Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Biochim Biophys Acta 1740:357–366
Iqbal M, Sharma SD, Okazaki Y et al (2003) Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Phamacol Toxicol 92:33–38. doi:10.1034/j.1600-0773.2003.920106.x
Iqbal M, Okazaki Y, Okada S (2003) In vitro curcumin modulates ferric nitrilotriacetate (Fe-NTA) and hydrogen peroxide (H2O2)-induced peroxidation of microsomal membrane lipids and DNA damage. Teratog Carcinog Mutagen Suppl 23:151–160. doi:10.1002/tcm.10070
Toyokuni S, Miyake N, Hiai H et al (1995) The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 35:189–191. doi:10.1016/0014-5793(95)00033-6
Toyokuni S, Tanaka T, Hattori Y et al (1997) Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76:365–374
Awai M, Nagasaki M, Yamanoi Y et al (1979) Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 95:663–672
Iqbal M, Sharma SD, Rahman A et al (1999) Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: implications for carcinogenesis. Cancer Lett 141:151–157. doi:10.1016/S0304-3835(99)00100-7
Iqbal M, Giri U, Giri DK et al (1999) Age-dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis. Arch Biochem Biophys 365:101–112. doi:10.1006/abbi.1999.1135
Hsu SM, Raine N, Fanger H (1981) A comparative study of the peroxidase–antiperoxidase method and an avidin–biotin complex method for studying polypeptide hormones with radio immunoassay antibodies. Am J Clin Pathol 75:734–738
Levine RL, Garland D, Oliver CN et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478. doi:10.1016/0076-6879(90)86141-H
Uchida K, Szweda LI, Chae HZ et al (1993) Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci USA 90:8742–8746. doi:10.1073/pnas.90.18.8742
Stadtman ER (2001) Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci 928:22–38
Levine RL (2002) Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 32:790–796. doi:10.1016/S0891-5849(02)00765-7
Wattenberg LW (1985) Chemoprevention of cancer. Cancer Res 45:1–8. doi:10.1016/S0065-230X(08)60265-1
Zhang D, Okada S, Yu Y et al (1997) Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 57:2410–2414
Boone CW, Kelloff GJ, Malone WE (1990) Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res 50:2–9
Wargovich MJ (1997) Experimental evidence for cancer preventive elements in foods. Cancer Lett 114:11–17. doi:10.1016/S0304-3835(97)04616-8
Ames BN, Gold LS, Willett WC (1995) The causes and prevention of cancer. Proc Natl Acad Sci USA 92:5258–5265. doi:10.1073/pnas.92.12.5258
Iqbal M, Giri U, Athar M (1995) Ferric nitrilotriacetate (Fe-NTA) is a potent hepatic tumor promoter and acts through the generation of oxidative stress. Biochem Biophys Res Commun 212:557–563. doi:10.1006/bbrc.1995.2006
Hsu DZ, Wan CH, Hsv HF, Lim YM (2008) The prophylactic protective effect of seasamol against ferric nitrilotriacetate-induced acute renal injury in mice. Food Chem Toxicol 46:2736–2741. doi:10.1093/carcin/20.4.599
Iqbal M, Rezazadeh H, Ansar S et al (1998) alpha-Tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress. Hum Exp Toxicol 17:163–171. doi:10.1191/096032798678908486
Iqbal M, Okazaki Y, Okada S (2007) Probucol modulates iron nitrilotriacetate (Fe-NTA) dependent renal carcinogenesis and hyperproliferative response: diminution of oxidative stress. Mol Cell Biochem 304:61–69. doi:10.1007/s11010-007-9486-6
Osawa T (2007) Nephroprotective and hepatoprotective effects of curcuminoids. Adv Exp Med Biol 58:407–423. doi:10.1007/978-0-387-46401-5_18
Eybl V, Kotyzova D, Cerna P, Koutensky J (2008) Effect of melatonin, curcumin, quercetin and resveratrol on acute ferric nitrilotriacetate induced renal oxidative damage in rats. Hum Exp Toxicol 27:347–353. doi:10.1177/0960327108094508
Kasai H (1997) Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387:147–163. doi:10.1016/S1383-5742(97)00035-5
Umemura T, Hasegawa R, Sai-Kato K et al (1996) Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate. Jpn J Cancer Res 87:882–886
Hermanns RC, de Zwart LL, Salemink PJ et al (1998) Urinary excretion of biomarkers of oxidative kidney damage induced by ferric nitrilotriacetate. Toxicol Sci 43:241–249
Akiyama T, Hamazaki S, Okada S (1995) Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate. Jpn J Cancer Res 86:1143–1149
Winter CK, Segall HJ, Haddon WF (1986) Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res 46:5682–5686
Chung FL, Chen HJC, Guttenplan JB et al (1993) 2,3-Epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation. Carcinogenesis 14:2073–2077. doi:10.1093/carcin/14.10.2073
Amici A, Levine RL, Tsai L et al (1989) Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. J Biol Chem 264:3341–3346
Uchida K, Stadtman ER (1992) Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci USA 89:4544–4548. doi:10.1073/pnas.89.10.4544
Szweda LI, Uchida K, Tsai L et al (1993) Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J Biol Chem 268:3342–3347
Uchida K, Stadtman ER (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra and intermolecular cross-linking reaction. J Biol Chem 268:6388–6393
Uchida K, Toyokuni S, Nishikawa K et al (1994) Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 33:12487–12494. doi:10.1021/bi00207a016
Acknowledgments
Authors are thankful to Japan Society for the Promotion of Science (JSPS) for providing grant-in-aid for scientific research to support these studies. Authors are also thankful to Dr. S. Toyokuni (Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Japan) for providing monoclonal antibody, HNEJ-2, specific for HNE-modified protein adducts and N45.1, specific for 8-OHdG, respectively. Authors are also thankful to Dr. Nur Asikin (School of Medicine, University Malaysia Sabah) for reading the manuscript and valuable suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iqbal, M., Okazaki, Y. & Okada, S. Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention. Mol Cell Biochem 324, 157–164 (2009). https://doi.org/10.1007/s11010-008-9994-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-008-9994-z